You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Osteonecrosis Due to Drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension, Osteonecrosis, Osteonecrosis Due to Drug Trial in San Diego, Charlotte, Memphis (Intensive Antihypertensive

Recruiting
  • Hypertension
  • +2 more
  • Intensive Antihypertensive Therapy
  • +3 more
  • San Diego, California
  • +2 more
Feb 8, 2022

Osteonecrosis Due to Drugs, Jaw Trial in Besançon (Human Amniotic Membrane, Conventional/Standard treatment)

Active, not recruiting
  • Osteonecrosis Due to Drugs, Jaw
  • Human Amniotic Membrane
  • Conventional/Standard treatment
  • Besançon, France
    CHU de Besancon
Dec 21, 2022

Osteonecrosis Due to Drugs, Jaw Trial in Copenhagen (Continuation of antiresorptives in relation to tooth extraction (surgical

Completed
  • Osteonecrosis Due to Drugs, Jaw
  • Continuation of antiresorptives in relation to tooth extraction (surgical tooth removal)
  • Copenhagen, Copenhagen Ø, Denmark
  • +1 more
Sep 7, 2020

Predictive Score For Maxillary Osteonecrosis After Invasive Oral

Terminated
  • Osteonecrosis Due to Drugs, Jaw
    • Aulnay-sous-Bois, France
    • +4 more
    Apr 21, 2022

    MEDICATION RELATED OSTEONECROSIS OF THE JAW Trial in Palermo (OZOPROMAF_SEQ1)

    Suspended
    • MEDICATION RELATED OSTEONECROSIS OF THE JAW
    • Palermo, Italy - Sicily, Italy
      Azienda Ospedaliera Universitaria Policlinico "P. Giaccone" Pale
    Sep 6, 2021

    Oral Mucositis, Osteoradionecrosis, Osteonecroses, Bisphosphonate Trial in Santiago De Compostela (Preventive, LLL Phototherapy

    Recruiting
    • Oral Mucositis
    • +6 more
    • Preventive, LLL Phototherapy and topical Vit E
    • +3 more
    • Santiago De Compostela, LA Coruña, Spain
      Hospital Clinico Universitário
    Feb 1, 2022

    Nocturia Due to Nocturnal Polyuria Trial in Tokyo (Desmopressin)

    Recruiting
    • Nocturia Due to Nocturnal Polyuria
    • Tokyo, Japan
      Survey Site (there may be other sites in this country)
    Jan 10, 2023

    Cancer, Ototoxicity, Drug-Induced, Quality of Life Trial (Patients suffering from chemo-induced ototoxicity)

    Not yet recruiting
    • Cancer
    • +3 more
    • Patients suffering from chemotherapy-induced ototoxicity
    • (no location specified)
    Jun 29, 2023

    Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)

    Not yet recruiting
    • Opioid Withdrawal (Disorder)
    • Standard of Care with Lofexidine
    • Standard of Care without Lofexidine
    • (no location specified)
    Sep 14, 2023

    Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

    Not yet recruiting
    • Crohn Disease
    • +4 more
    • TDM-based infliximab intravenous therapy
    • Standard infliximab intravenous therapy
    • (no location specified)
    Sep 26, 2023

    Gain Information on Drug Xarelto for Prevention of Brain Attack

    Completed
    • Non-valvular Atrial Fibrillation (NVAF)
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Multiple Locations, Taiwan
      Many Locations
    Jan 29, 2023

    Denmark, Germany and Sweden

    Recruiting
    • Adverse Drug Event
    • NOCDURNA Cohort
    • LUTS Cohort
    • Bremen, Germany
      German health care register, BIPS (there may be other sites)
    May 9, 2022

    Bile Acids in Acute Insulin Resistance

    Recruiting
    • PI3K Gene Mutation
    • +4 more
    • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    Macular Edema Trial in United States (Updated Dexamethasone Posterior Segment Drug Delivery System, Approved Dexamethasone

    Completed
    • Macular Edema
    • Updated Dexamethasone Posterior Segment Drug Delivery System
    • Approved Dexamethasone Posterior Segment Drug Delivery System
    • Glendale, California
    • +6 more
    Feb 11, 2022

    Breast Cancer Trial in São Paulo (Drug omission, Control group)

    Active, not recruiting
    • Breast Cancer
    • Drug omission
    • Control group
    • São Paulo, SP, Brazil
      Vanessa Scontre
    Aug 24, 2021

    Paclitaxel-induced Polyneuropathy in Breast Cancer: Early

    Not yet recruiting
    • Breast Neoplasms
    • +7 more
    • Garmin smartwatch
    • +2 more
    • Solna, Stockholm, Sweden
      Karolinska University Hospital
    Sep 18, 2023

    2D Speckle-tracking Echocardiography in Chemotherapy-induced

    Recruiting
    • Cardiomyopathy Due to Drug
    • +2 more
    • Echocardiography
    • Ho Chi Minh, Vietnam
      Nguyen Hoang Hai
    Aug 9, 2022

    Adult and Child Patients and Parents of Swelling Due to

    Recruiting
    • Fluid Overload
    • +12 more
    • Interview
    • Ann Arbor, Michigan
      University of Michigan
    Aug 16, 2022

    Acute Cellular Graft Rejection, Cardiac Sarcoidosis, Myocarditis Due to Drug Trial in Lausanne ([68Ga]Ga-PentixaFor PET/CT)

    Not yet recruiting
    • Acute Cellular Graft Rejection
    • +2 more
    • [68Ga]Ga-PentixaFor PET/CT
    • Lausanne, Vaud, Switzerland
      Centre Hospitalier Universitaire Vaudois
    Aug 11, 2022

    Osteoarthritis, Knee, Knee Osteoarthritis, Knee Arthritis Trial in United States (4 mL injection of Ampion, 4 mL Injection of

    Completed
    Has Results
    • Osteoarthritis, Knee
    • +3 more
    • 4 mL injection of Ampion
    • 4 mL Injection of Placebo
    • Birmingham, Alabama
    • +12 more
    Aug 8, 2022

    Asthma Trial in Wellesley (insurance navigation)

    Completed
    Has Results
    • Asthma
    • insurance navigation
    • Wellesley, Massachusetts
      Harvard Pilgrim Health Care
    Mar 7, 2022

    Severe Osteoarthritis of the Knee Trial in United States (Ampion)

    Terminated
    Has Results
    • Severe Osteoarthritis of the Knee
    • 4 mL injection of AMPION™
    • Birmingham, Alabama
    • +10 more
    Sep 21, 2022

    Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis Trial (Alendronate Sodium)

    Not yet recruiting
    • Sickle Cell Disease
    • +4 more
    • Alendronate Sodium
    • (no location specified)
    Sep 6, 2023

    Mental and Behavioral Disorders Due to Harmful Drug Use Trial in New York (HealthCall and Motivational Interviewing,

    Completed
    Has Results
    • Mental and Behavioral Disorders Due to Harmful Drug Use
    • HealthCall and Motivational Interviewing
    • +2 more
    • New York, New York
    • +1 more
    Aug 15, 2021

    Ventilator Associated Pneumonia Trial in Chandigarh (Duration of antibiotic)

    Active, not recruiting
    • Ventilator Associated Pneumonia
    • Duration of antibiotic
    • Chandigarh, India
    • +1 more
    Aug 2, 2021